IBC Protocol Submission & Review

Musts Before Starting Research:

  • Determine whether the research is subject to Section III-A, III-B, III-C, III-D, or III-E of the NIH Guidelines.
  • Propose physical and biological containment levels in accordance with the NIH Guidelines when registering research with the IBC.
  • Propose appropriate microbiological practices and laboratory techniques to be used for the research.
  • Submit a research protocol to the IBC for review and approval.
  • Seek NIH OSP’s determination regarding containment for experiments that require case-by-case review.
  • Petition NIH OSP, with notice to the IBC, for proposed exemptions from the NIH Guidelines.
  • Obtain IBC approval before initiating research subject to the NIH Guidelines.
  • Seek NIH approval, in addition to IBC approval, to conduct experiments specified in Sections III-A and III-B of the NIH Guidelines.

1. Submit Required Documentation

A. Environmental Health and Safety (EHS) should be contacted for training requirements and further instruction.

B. Complete the appropriate protocol application available on Research Compliance System (RCS):

C. If the protocol is working with animals, an approved IACUC protocol is also required.

D. If the protocol involves use of human research subjects, an approved IRB protocol is also required.

2. Protocol Draft Review

Pre-Review is conducted by an IBC Compliance Administrator, and Environmental Health and Safety (EHS). The pre-review may involve revisions, clarifications and modifications to the protocol before review by the IBC Chair or IBC Committee. Required training will be verified for completion.

3. Committee Review

The IBC reviews projects by Full Committee Review (FCR).

4. Communicate Outcome

Utilizing the electronic protocol system, the IBC will notify investigators in writing of its decision to approve or withhold approval of protocols, or when modifications are required to secure IBC approval.

Musts During Research:

  • Determine the need for IBC review before modifying recombinant or synthetic nucleic acid research already approved by the IBC.
  • Submit any subsequent changes (e.g., changes in the source of DNA or host-vector system) to the IBC for review and approval or disapproval.
  • Remain in communication with the IBC throughout the duration of the project.
  • Report any significant problems pertaining to the operation and implementation of containment practices and procedures, violations of the NIH Guidelines, or any significant research-related accidents and illnesses to the IBC, NIH OSP, and, as applicable, the Biological Safety Officer, Greenhouse or Animal Facility Director, and other appropriate authorities.

If you have any questions or concerns, please contact the IBC Compliance Administrator.